Free Trial
NASDAQ:TMCI

Treace Medical Concepts (TMCI) Stock Price, News & Analysis

Treace Medical Concepts logo
$6.22 +0.06 (+0.97%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$6.24 +0.02 (+0.32%)
As of 08:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Treace Medical Concepts Stock (NASDAQ:TMCI)

Key Stats

Today's Range
$6.04
$6.26
50-Day Range
$5.44
$7.52
52-Week Range
$4.54
$10.79
Volume
220,758 shs
Average Volume
518,693 shs
Market Capitalization
$391.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.16
Consensus Rating
Hold

Company Overview

Treace Medical Concepts Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

TMCI MarketRank™: 

Treace Medical Concepts scored higher than 50% of companies evaluated by MarketBeat, and ranked 536th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Treace Medical Concepts has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 2 buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Treace Medical Concepts has only been the subject of 2 research reports in the past 90 days.

  • Read more about Treace Medical Concepts' stock forecast and price target.
  • Earnings Growth

    Earnings for Treace Medical Concepts are expected to grow in the coming year, from ($0.92) to ($0.77) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Treace Medical Concepts is -7.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Treace Medical Concepts is -7.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Treace Medical Concepts has a P/B Ratio of 3.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Treace Medical Concepts' valuation and earnings.
  • Percentage of Shares Shorted

    6.25% of the float of Treace Medical Concepts has been sold short.
  • Short Interest Ratio / Days to Cover

    Treace Medical Concepts has a short interest ratio ("days to cover") of 6.7.
  • Change versus previous month

    Short interest in Treace Medical Concepts has recently increased by 4.10%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Treace Medical Concepts does not currently pay a dividend.

  • Dividend Growth

    Treace Medical Concepts does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.25% of the float of Treace Medical Concepts has been sold short.
  • Short Interest Ratio / Days to Cover

    Treace Medical Concepts has a short interest ratio ("days to cover") of 6.7.
  • Change versus previous month

    Short interest in Treace Medical Concepts has recently increased by 4.10%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Treace Medical Concepts has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Treace Medical Concepts this week, compared to 7 articles on an average week.
  • MarketBeat Follows

    1 people have added Treace Medical Concepts to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Treace Medical Concepts insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    27.72% of the stock of Treace Medical Concepts is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    84.08% of the stock of Treace Medical Concepts is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Treace Medical Concepts' insider trading history.
Receive TMCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Treace Medical Concepts and its competitors with MarketBeat's FREE daily newsletter.

TMCI Stock News Headlines

TMCI Treace Medical Concepts, Inc. - Seeking Alpha
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

TMCI Stock Analysis - Frequently Asked Questions

Treace Medical Concepts' stock was trading at $7.44 at the start of the year. Since then, TMCI stock has decreased by 16.4% and is now trading at $6.22.

Treace Medical Concepts, Inc. (NASDAQ:TMCI) released its quarterly earnings data on Thursday, May, 8th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.31) by $0.06. The business's revenue was up 2.9% on a year-over-year basis.
Read the conference call transcript
.

Treace Medical Concepts (TMCI) raised $150 million in an IPO on Friday, April 23rd 2021. The company issued 9,400,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Shares of TMCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Treace Medical Concepts investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), Waste Connections (WCN), AU Optronics (AUOTY), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/08/2025
Today
7/10/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:TMCI
CIK
1630627
Fax
N/A
Employees
250
Year Founded
N/A

Price Target and Rating

High Price Target
$16.00
Low Price Target
$8.00
Potential Upside/Downside
+63.3%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$55.74 million
Pretax Margin
-25.14%

Debt

Sales & Book Value

Annual Sales
$209.36 million
Price / Cash Flow
N/A
Book Value
$1.81 per share
Price / Book
3.44

Miscellaneous

Free Float
45,457,000
Market Cap
$391.18 million
Optionable
Optionable
Beta
0.69
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:TMCI) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners